- Home
- ICCC vs SPCB Comparison
ICCC vs SPCB Comparison
Compare ICCC & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- SPCB
- Stock Information
- Founded
- ICCC 1982
- SPCB 1988
- Country
- ICCC United States
- SPCB Israel
- Employees
- ICCC N/A
- SPCB N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- SPCB Semiconductors
- Sector
- ICCC Health Care
- SPCB Technology
- Exchange
- ICCC Nasdaq
- SPCB Nasdaq
- Market Cap
- ICCC 60.1M
- SPCB 53.3M
- IPO Year
- ICCC 1987
- SPCB N/A
- Fundamental
- Price
- ICCC $6.71
- SPCB $9.72
- Analyst Decision
- ICCC
- SPCB Strong Buy
- Analyst Count
- ICCC 0
- SPCB 1
- Target Price
- ICCC N/A
- SPCB $18.00
- AVG Volume (30 Days)
- ICCC 41.8K
- SPCB 166.8K
- Earning Date
- ICCC 08-12-2025
- SPCB 08-14-2025
- Dividend Yield
- ICCC N/A
- SPCB N/A
- EPS Growth
- ICCC N/A
- SPCB N/A
- EPS
- ICCC N/A
- SPCB 1.89
- Revenue
- ICCC $27,302,766.00
- SPCB $27,831,000.00
- Revenue This Year
- ICCC N/A
- SPCB $2.73
- Revenue Next Year
- ICCC N/A
- SPCB $22.87
- P/E Ratio
- ICCC N/A
- SPCB $5.16
- Revenue Growth
- ICCC 28.29
- SPCB 2.90
- 52 Week Low
- ICCC $3.34
- SPCB $2.55
- 52 Week High
- ICCC $7.60
- SPCB $18.95
- Technical
- Relative Strength Index (RSI)
- ICCC 49.68
- SPCB 47.89
- Support Level
- ICCC $5.63
- SPCB $9.61
- Resistance Level
- ICCC $7.14
- SPCB $11.14
- Average True Range (ATR)
- ICCC 0.64
- SPCB 0.68
- MACD
- ICCC -0.06
- SPCB -0.22
- Stochastic Oscillator
- ICCC 42.58
- SPCB 17.44
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.